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Abstract 22 
Background: Several studies have shown an increased prevalence of right-to-left shunt 23 
(RLs) in migraine patients, particularly those with aura. However, the prevalence of RLs and 24 
its relation to Japanese patients with migraine are unknown. We investigated the prevalence 25 
of RLs in Japanese patients with migraine. 26 
Methods: In total, 112 consecutive patients with migraine were recruited from our headache 27 
outpatient clinic. Migraine with aura (MA) and migraine without aura (MWOA) were 28 
diagnosed according to the International Classification of Headache Disorders, 3rd edition 29 
(beta-version). Contrast transcranial Doppler ultrasound was used to detect RLs, including 30 
patent foramen ovale (PFO). Then, the associations between RLs and patients’ backgrounds 31 
and presence of aura were assessed.  32 
Results: The overall prevalence of RLs and PFO in migraine patients was 54.5% and 43.8%, 33 
respectively. The prevalence of RLs and PFO in the MA group were significantly higher than 34 
in the MWOA group (RLS, 62.9% vs. 44.0%, p=0.046; PFO, 54.8% vs. 30.0%, p=0.008). 35 
There were no marked differences in the prevalence of large, middle and small shunts 36 
between MA and MWOA patients. Compared with the MWOA patients, the MA patients 37 
were younger (p=0.013) and had early onset age (p=0.013) and increased prevalence of 38 
photophobia (p=0.008).      39 
Conclusion: RLs were found in over half of the Japanese patients with migraine. Our study 40 
suggests a possible link between RLs and MA. 41 
 42 
Key words: migraine, right-to-left shunt, patent foramen ovale, transcranial ultrasonography, 43 
migraine with aura, pulmonary arteriovenous malformation 44 
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Introduction 46 
Patent foramen ovale (PFO) is a condition in which the foramen ovale, which normally closes 47 
at birth due to the elevation in the left atrial pressure during the transition to pulmonary 48 
circulation, is left unclosed (1). It has been reported that 15%-35% of healthy people have 49 
PFO (2, 3). PFO causes the formation of right-to-left shunts (RLs) during the Valsalva 50 
maneuver or at rest. Although several diseases, such as arteriovenous malformation (AVM) or 51 
atrial septum deficits, can cause RLs, PFO is the most common underlying factor for RLs (4). 52 
A relationship between PFO and migraine has been reported. One hypothesis is that the 53 
passage of metabolic substances or subclinical emboli through a PFO stimulates the 54 
trigeminal nerve and cerebrovascular system, evoking migraine-like headaches (5). Although 55 
several studies reported no relationship between migraine and PFO (5), 40%-70% of patients 56 
with migraine with aura (MA) have been reported to have PFO (6). Additionally, an increased 57 
prevalence of PFO has been described in patients with chronic migraine compared to the 58 
general population and other headache groups (7). An increased prevalence of RLs has been 59 
found in patients with migraine, especially those with MA, in several cross-sectional studies; 60 
however, this relationship has not been replicated in population-based studies (8, 9) and the 61 
association between migraine and RLs has not been well studied in Asian populations. 62 
We conducted a single-center, cross-sectional study consisting of consecutive migraine 63 
patients from a headache outpatient clinic to explore the prevalence of RLs and its associated 64 
features in Japanese patients with migraine and to test our hypothesis that patients with 65 
migraine with aura are associated with the presence of RLs. 66 
 67 
Objective and Methods 68 
Between April 2014 and May 2016, 119 consecutive migraine patients (mean age 39.8±13.0 69 
years, 7 men and 112 women) were recruited from our headache outpatient clinic at the 70 
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Department of Neurology of Dokkyo Medical University Hospital. Seven patients were 71 
excluded from the study: six because of a loss in permeability during transcranial Doppler 72 
(TCD) evaluation of temporal bones and one due to insufficient information about migraine. 73 
Ultimately, 112 patients (mean age 38.6±12.2 years, 6 men and 106 women) were included in 74 
our study. MA and migraine without aura (MWOA) were diagnosed by headache specialists 75 
(RT, SS and KH) in accordance with the International Classification of Headache Disorders 76 
3rd edition (beta-version) (10). Clinical information, including smoking status and onset age 77 
of migraine; family history of migraine; sensitivity to light, sound or smell; and comorbid 78 
diseases such as hypertension, dyslipidemia and diabetes mellitus, was obtained by 79 
questioning the patients. The clinical characteristics and prevalences of RLs were compared 80 
between the MA and MWOA groups. The institutional review board of Dokkyo Medical 81 
University Hospital approved the study (IRB approved number: 25028). All of the patients 82 
provided their written informed consent to participate.  83 
 84 
Diagnosis of right-to-left shunts 85 
RLs was assessed in all the patients by transcranial Doppler ultrasound (TCD; Pioneer 86 
TC8080 System; Nicolet Vascular, Tokyo, Japan) with intravenous injection of agitated saline 87 
with microbubbles by trained neurologists (AI, HT and AS). The M1 portion of the right 88 
middle cerebral artery (MCA) was depicted using a 2-MHz probe securely fixed by a 89 
headband through a gap in the temporal bone window. High-intensity transient signals 90 
(HITSs) were defined as strong transient signals (within 100 msec duration) that appeared in 91 
the same direction as the blood flow, with the intensity being at least 3-dB higher than the 92 
background reflecting the blood stream, in accordance with the criteria proposed by national 93 
consensus (11, 12). The sampling volume was set to within 8 to 10 mm, and the depth was set 94 
to between 50 and 55 mm. 95 
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At first, prior to the intravenous injection of contrast agent, simple observation was 96 
performed for 20 minutes. The HITS detection threshold volume was set to >6 dB. Then, 97 
10 ml of contrast agent (a mixture of 9 ml saline and 1 ml air) was injected intravenously 98 
during the Valsalva maneuver. If HITSs were detected within 10 seconds after Valsalva load 99 
release, PFO was diagnosed. Next, careful observation was made to detect HITS for 3 100 
minutes after Valsalva load release. If HITSs were detected within 3 minutes, additional 101 
observation was made for 3 minutes. Contrast agent was then injected intravenously without 102 
the Valsalva maneuver, and we continued observation for another 3 minutes. If HITSs were 103 
detected without Valsalva load, PFO or pulmonary AVM (pAVM) was diagnosed (13). Large 104 
shunts were defined as > 26 HITSs, and middle shunts were defined as 5-26 HITSs. The 105 
same procedure was repeated 3 times for all patients (Fig. 1). 106 
 107 
Statistical analyses 108 
All data are described as proportions (%) and medians (range) or means (±standard deviation). 109 
The patients were classified into the MA or MWOA groups based on the presence of aura. 110 
Univariate analyses were conducted to compare the characteristics between the two groups. 111 
The chi-square test and Mann-Whitney U test were used to compare the characteristics 112 
between the MA and MWOA groups. All p-values were two-tailed, and p-values <0.05 were 113 
considered significant. All statistical analyses were performed using the IBM SPSS® software 114 
program for Mac, ver. 23 (Tokyo, Japan). 115 
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Results 117 
Detection of RLs 118 
A total of 112 subjects (106 women, median age, 39.0 years, range 14-74 years) underwent 119 
the TCD examination. On simple observation, prior to intravenous injection, HITSs were not 120 
detected in any patients. Next, during a 3-minute observation period after contrast agent 121 
injection with the Valsalva maneuver, HITSs were detected in 61 subjects (54.5%). With 122 
contrast agent administration at rest, HITSs were detected in 12 subjects (10.7%). Based on 123 
these results, a total of 49 subjects (43.8%) were diagnosed with PFO, and 12 subjects 124 
(10.7%) were diagnosed with PFO or pAVM (Fig. 1). The maximum numbers of HITSs per 125 
examination were as follows: 1-5 HITSs, 40 subjects; 5-26 HITSs, 7 subjects; > 26 HITSs, 14 126 
subjects.  127 
 128 
Comparison between MA and MWOA    129 
Among the 112 patients with migraine, 62 had MA and 50 had MWOA. The median ages of 130 
the MA and MWOA groups were 37.5 and 40.5 years old. The MA group was significantly 131 
younger than the MWOA group (p=0.013). Similarly, the onset age was also younger in the 132 
MA patients than in the MWOA patients (p=0.013). Among the total cohort, 74 subjects 133 
(66.1%) had a family history of migraine. Photophobia (75.9%), phonophobia (74.1%), and 134 
hypersensitivity to smell (56.3%) were commonly observed. Photophobia was more frequent 135 
in the MA group than in the MWOA group (86.2% vs. 64.0%, p=0.008). However, there was 136 
no significant difference in the prevalence of phonophobia, hypersensitivity to smell, altered 137 
taste, or allodynia between the MA and MWOA groups (Table 1). 138 
The prevalence of RLs was significantly higher in the MA group (62.9%) than in the 139 
MWOA group (44.0%) (p=0.046) (Figure 2). In addition, a higher prevalence of PFO was 140 
observed in the MA group than in the MWOA group (54.8% vs. 30.0%, p=0.008) (Table 2). 141 
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Concerning the shunt sizes, there were no differences in the prevalence of large, middle, and 142 
small shunts between MA and MWOA patients. 143 
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Discussion 145 
In our study, we investigated the prevalence of RLs and its relationship with clinical 146 
background factors, including type of migraine. A main finding from our study is that a high 147 
prevalence of RLs (54.5%), especially in patients with aura (62.9%), was observed among 148 
Japanese patients with migraine, which is comparable to that reported in European studies (5, 149 
6). PFO is a well-known cause of paradoxical embolism (1), and the prevalence of PFO in 150 
healthy people ranges from 15% to 35% (2, 3, 14). Patients with migraine, particularly those 151 
with MA, have been reported to have an increased prevalence of PFO compared to 152 
individuals without migraine (6, 15, 16). A recent meta-analysis showed that PFO is 153 
associated with 2.5-fold total migraine and 3.4-fold MWA prevalence, but not with MWOA 154 
prevalence (17) In our study, we confirmed increased the prevalence of PFO in the MA group 155 
compared with the MWOA group (62.9% vs. 44.0%, p=0.046), in line with the results of 156 
previous studies (15, 17).  157 
Increased prevalence of photophobia in MA patients compared with MWOA patients 158 
was observed in our study, which is in agreement with the findings from a study of 5,758 159 
adult residents in Japan (18) that showed a photophobia rate of 43.9% and 17.9% in Japanese 160 
patients with MA and MWOA, respectively. The prevalence of RLs and PFO was 161 
significantly increased in the MA group compared with the MWOA group. However, there 162 
was no marked difference in the shunt sizes between the groups in our study. Schwerzmann et 163 
al. (19) reported increased rates of moderate or large shunts in the migraine group compared 164 
with control groups. Contrary to our report, Yang et al. (20) showed increased rates of total 165 
and large RLs but not small RLs in patients with MA compared with MWOA. As for 166 
intrapulmonary RLs, van Gent et al. (21) reported the increased prevalence of large shunts in 167 
MA patients compared with MWOA patients. These differences might be due to 168 
discrepancies in methodologies or populations.    169 
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Regarding the mechanism underlying the potential relationship between PFO and 170 
migraine, PFO may allow vasoactive chemicals, such as serotonin and endothelin, or embolic 171 
material to bypass the pulmonary filter and reach the cerebral circulation to induce a migraine 172 
attack (15, 22). Additionally, paradoxical air microemboli through the PFO may induce 173 
cerebral electrical activity, triggering migraine attacks (23).  174 
The effect of PFO closure on migraine has also been controversial. In several studies, 175 
PFO closure has successfully reduced the intensity and severity of migraine attacks (24), 176 
while in a double-blind randomized study that included with migraine, PFO closure failed to 177 
reduce migraine intensity and severity (9). Further discussions are needed in this point. 178 
Several limitations associated with the present study warrant mention. First, this study 179 
used a cross-sectional design, and healthy controls were not included. According to previous 180 
studies, 15%-35% of healthy Caucasian and African-descent subjects have PFO (2, 3). To our 181 
knowledge, there has been no clinical study evaluating the PFO prevalence in healthy 182 
Japanese subjects. One autopsy study showed the PFO prevalence to be 13.6% in 109 183 
Japanese adults (mean age 69 years) and even lower (7.0%) in those ≤ 59 years of age (25). 184 
Second, not all patients with migraine who were seen in our hospital underwent a TCD 185 
examination; therefore, selection bias might have affected the study’s results. The 186 
male:female ratio is lower in our study (1:16) than in a population-based study of migraine 187 
patients in Japan (1:3.6) (26). Third, MA patients were younger and had earlier migraine 188 
onset MWOA patients. Although the prevalence of PFO decreases with age (14), given that 189 
the age gap between the MA and MWOA groups was only three years, we believe the 190 
influence of age difference had little impact on the RLs prevalence. 191 
 192 
Conclusions 193 
RLs were found in over half of a cohort of Japanese patients with migraine. Our study 194 
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suggests a possible link between RLs and MA in Japanese.  195 
 196 
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Figure legends 290 
Figure 1: Flowchart for the diagnosis of right-to-left shunts. RLs: Right-to-left shunts; TCD: 291 
transcranial Doppler; HITS: High-intensity transient signals; PFO: Patent foramen ovale.  292 
 293 
Figure 2: Prevalence of RLs in the MWOA and MWA groups. MA: Migraine with aura; 294 
MWOA: Migraine without aura; RLs: Right-to-left shunts. Chi-square test. 295 
